Css LLC Viatris Inc Call Options Transaction History

Css LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$10.32 - $12.13 $25,800 - $30,325	-2,500 Reduced 14.12%	15,200 $176,000
Q2 2024 Aug 14, 2024	SELL	$10.05 - $12.02 $253,260 - $302,904	-25,200 Reduced 58.74%	17,700 $188,000
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $759,598 - $911,922	-67,400 Reduced 61.11%	42,900 $512,000
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $245,560 - $303,800	28,000 Added 34.02%	110,300 $1.19 Million
Q3 2023 Nov 14, 2023	BUY	$9.59 - $11.35 $46,032 - $54,480	4,800 Added 6.19%	82,300 $811,000
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $699,050 - $797,474	77,500 New	77,500 $773,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.